ArriVent BioPharma, Inc.

AVBP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001868279

SEC filings (opens in a new tab)

No open-market purchases or sales by ArriVent BioPharma, Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.60B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding ArriVent BioPharma, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of AVBP: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	139	2	157	+20
Shares	42.1M	14.5K	46.1M	+4.05M (+9.6%)
Value	$969.5M	$334.9K	$1.60B	+$632.6M (+65.3%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held ArriVent BioPharma, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to AVBP in Q2 2026
Institution	Shares	Value	% of portfolio
Foresite Capital Management VI LLC	301,341	$10.5M	1.63%
Acuta Capital Partners, LLC	218,694	$7.60M	5.29%
KVP Capital Advisors, LP	102,000	$3.54M	2.60%
Trexquant Investment LP	71,860	$2.50M	0.02%
Toroso Investments, LLC	57,034	$1.98M	0.00%
Tema ETFs LLC	57,034	$1.98M	0.06%
Soleus Capital Management, L.P.	50,000	$1.74M	0.06%
Ellsworth Advisors, LLC	27,001	$889.7K	0.15%
Engineers Gate Manager LP	22,259	$773.3K	0.01%
Sound Capital Solutions LLC	18,851	$654.9K	0.15%
Fox Run Management, L.L.C.	11,898	$413.3K	0.07%
Y-Intercept (Hong Kong) Ltd	11,843	$411.4K	0.01%
Jain Global LLC	11,487	$399.1K	0.00%
DeepCurrents Investment Group LLC	11,227	$390.0K	0.01%
Creative Planning	10,013	$347.9K	0.00%
State of Wisconsin Investment Board	9,883	$343.3K	0.00%
State Board of Administration of Florida Retirement System	9,375	$325.7K	0.00%
Brevan Howard Capital Management LP	8,823	$306.5K	0.00%
VARCOV Co.	8,151	$283.2K	0.11%
State of New Jersey Common Pension Fund D	7,861	$273.1K	0.00%
Envestnet Asset Management Inc	7,472	$259.6K	0.00%
Martingale Asset Management L P	7,103	$246.8K	0.01%
PSP Research LLC	7,041	$244.6K	0.13%
Arizona State Retirement System	6,708	$233.0K	0.00%
Morgan Creek Capital Management, LLC	6,600	$229.3K	0.15%
Jupiter Topco LLC	6,500	$225.6K	0.00%
ProShare Advisors LLC	6,491	$225.5K	0.00%
Simplex Trading, LLC	6,428	$223.3K	0.01%
Prudential Financial Inc	6,215	$215.9K	0.00%
Pacer Advisors, Inc.	407	$14.0K	0.00%
SJS Investment Consulting Inc.	27	$938	0.00%
Massmutual Trust Co FSB	22	$764	0.00%
Fifth Third Bancorp	9	$313	0.00%
Silver Grove Financial Group, Inc.	8	$278	0.00%
Clearstead Advisors, LLC	4	$139	0.00%

Sold out (15)

Institutions that held ArriVent BioPharma, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of AVBP in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Fund 1 Investments, LLC	499,990	$11.5M
ADAR1 Capital Management, LLC	141,814	$3.27M
Polymer Capital Management (HK) LTD	122,276	$2.82M
Qube Research & Technologies Ltd	70,317	$1.62M
Jones Hill Capital LP	45,809	$1.06M
Marshall Wace, LLP	35,165	$811.3K
Man Group plc	20,727	$478.2K
ExodusPoint Capital Management, LP	19,025	$438.9K
Jane Street Group, LLC	17,658	$407.4K
Los Angeles Capital Management LLC	17,308	$399.3K
IvyRock Asset Management (HK) Ltd	16,000	$369.1K
MAI Capital Management	19	$439
Root Financial Partners, LLC	18	$415
True Wealth Design, LLC	6	$139
Keating Financial Advisory Services, Inc.	1	$23

Not filed for Q2 2026 yet (2)

Institutions that held ArriVent BioPharma, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AVBP in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Skopos Labs, Inc.	14,125	$325.9K
CWM, LLC	392	$9.04K